Apotex Health Corp experienced three significant sell transactions on September 18, 2026, totaling 850 million CAD. Major shareholders, including SK Artemis Holdings II and API Investment LP, alongside director Allan Grant Oberman, offloaded shares. This activity follows a 10.2% decline in stock value over the past quarter, preceding the upcoming November earnings report.